Cohort Profile Update: The Adverse Events Questionnaire of Medications and Vaccines (ADE-Q) in the Estonian Biobank
Authors:
- Kristi KrebsKKKristi Krebs
- Jelisaveta DžigurskiJDJelisaveta Džigurski
- Andres MetspaluAMAndres Metspalu
- Tõnu EskoTETõnu Esko
Open Access
- 14 October 2026
- journal article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 55 (6)
Abstract
No abstract availableKeywords
Funding Information
- Eesti Teadusagentuur (PRG184)
- Eesti Teadusagentuur (PRG2625)
- Eesti Teadusagentuur (PSG776)
- Norway Grants “Green ICT” program (EU53928)
- Norwegian Financial Mechanism
- European Commission
- European Union’s Horizon Europe Action (101057639)
- European Union or the Health and Digital Executive Agency
This publication has 20 references indexed in Scilit:
- Use of medications with pharmacogenomic guidelines and adverse outcomes in hospitalised older patients: a retrospective cross-sectional studyThe Pharmacogenomics Journal, 2026
- The potential bidirectional relationship between long COVID and menstruationNature Communications, 2025
- Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian BiobankEuropean Journal of Human Genetics, 2025
- The Estonian Biobank’s journey from biobanking to personalized medicineNature Communications, 2025
- Menstrual Cycle Length Changes Following Vaccination Against Influenza Alone or With COVID-19JAMA Network Open, 2025
- Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review UpdateDrug Safety, 2023
- Factors associated with underreporting of adverse drug reactions by patients: a systematic reviewInternational Journal of Clinical Pharmacy, 2023
- HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccinationHuman Genetics and Genomics Advances, 2022
- Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational StudiesDrug Safety, 2015
- The genetic basis of variability in drug responsesNature Reviews Drug Discovery, 2002